Mulberroside A 및 Oxyresveratrol의 병용 처리에 의한 미백 시너지 효과
Synergistic Hypopigmentation Effects of Mulberroside A and Oxyresveratrol
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Melasma is an acquired hyper-melanosis characterized by irregular light to dark brown macules and patches on sun-exposed areas of the skin. Topical treatments of melasma involve the use of hypo-pigmenting agents which modifies various stages of melanogenesis. The most common mode of action for hypo-pigmentation is the inhibition of the tyrosinase. Mulberroside A and oxyresveratrol, well known tyrosinase inhibitors, are found frequently together in natural products. The aim of the experiment is to find out the synergism in decreasing pigmentation by mulberroside A and oxyresveratrol. B16F10 murine melanoma cells were used for identification of melanin content and cell viability. In addition, inhibition against tyrosinase, a key enzyme for melanin synthesis, was determined. Single treatment of mulberroside A or oxyresveratrol exhibited dose-dependent inhibition of mushroom tyrosinase activity, which showed a reduction of extra melanin in B16F10 melanoma cells. Interestingly, while mulberroside A or oxyresveratrol rarely reduced melanin inside the melanocytes alone, their mixture could significantly attenuate the production of intracellular melanin, which might be manifested as synergistic hypopigmenting effects. Further studies are needed to understand the mechanism of synergism by mulberroside A and oxyresveratrol in the inhibition of melanin synthesis.
Abstract
Melasma is an acquired hyper-melanosis characterized by irregular light to dark brown macules and patches on sun-exposed areas of the skin. Topical treatments of melasma involve the use of hypo-pigmenting agents which modifies various stages of melanogenesis. The most common mode of action for hypo-pigmentation is the inhibition of the tyrosinase. Mulberroside A and oxyresveratrol, well known tyrosinase inhibitors, are found frequently together in natural products. The aim of the experiment is to find out the synergism in decreasing pigmentation by mulberroside A and oxyresveratrol. B16F10 murine melanoma cells were used for identification of melanin content and cell viability. In addition, inhibition against tyrosinase, a key enzyme for melanin synthesis, was determined. Single treatment of mulberroside A or oxyresveratrol exhibited dose-dependent inhibition of mushroom tyrosinase activity, which showed a reduction of extra melanin in B16F10 melanoma cells. Interestingly, while mulberroside A or oxyresveratrol rarely reduced melanin inside the melanocytes alone, their mixture could significantly attenuate the production of intracellular melanin, which might be manifested as synergistic hypopigmenting effects. Further studies are needed to understand the mechanism of synergism by mulberroside A and oxyresveratrol in the inhibition of melanin synthesis.
참고문헌 (15)
- Bandyopadhyay, D., "Topical treatment of melasma", Indian Journal of Dermatology, 54, pp.303~ (2009)
- Erdogan Orhan, I., "Flavonoid derivatives as potent tyrosinase inhibitors–a survey of recent findings between 2008-2013", Current Topics in Medicinal Chemistry, 14, pp.1486~1493 (2014)
- Kang, H., "The dermal stem cell factor and c‐kit are overexpressed in melasma", British Journal of Dermatology, 154, pp.1094~1099 (2006)
- Kang, W, "Melasma: histopathological characteristics in 56 Korean patients", British Journal of Dermatology, 146, pp.228~237 (2002)
- Kim, E.H, "The vascular characteristics of melasma", Journal of Dermatological Science, 46, pp.111~116 (2007)
- Kim, J.-K, "Biotransformation of mulberroside A from Morus alba results in enhancement of tyrosinase inhibition", Journal of Industrial Microbiology & Biotechnology, 37, pp.631~637 (2010)
- Kim, J.-K, "Evaluation of the inhibition of mushroom tyrosinase and cellular tyrosinase activities of oxyresveratrol: comparison with mulberroside A", Journal of Enzyme Inhibition and Medicinal Chemistry, 27, pp.495~503 (2012)
- Kim, Y.M, "Oxyresveratrol and hydroxystilbene compounds inhibitory effect on tyrosinase and mechanism of action", Journal of Biological Chemistry, 277, pp.16340~16344 (2002)
- Liang, C, "Dioscin: a synergistic tyrosinase inhibitor from the roots of Smilax china", Food Chemistry, 134, pp.1146~1148 (2012)
- Nguyen, N.T., "MITF and UV responses in skin: From pigmentation to addiction", Pigment Cell & Melanoma Research, 32, pp.224~236 (2019)
- Passeron, T., "Melasma, a photoaging disorder", Pigment Cell & Melanoma Research, 31, pp.461~465 (2018)
- Rendon, M, "Treatment of melasma", Journal of the American Academy of Dermatology, 54, pp.S272~S281 (2006)
- Serre, C., "Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation", International Journal of Cosmetic Science, 40, pp.328~347 (2018)
- Shin, N.-H, "Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase", Biochemical and Biophysical Research Communications, 243, pp.801~803 (1998)
- Wasmeier, C, "Melanosomes at a glance", Journal of Cell Science, 121, pp.3995~3999 (2008)
